Literature DB >> 9591808

Vitiligo.

S O Kovacs1.   

Abstract

The destruction of melanocytes is the cause of depigmented maculae that clinically represent the disease vitiligo. Although the cause is unknown, various theories such as the autoimmune, autocytotoxic, and neural hypotheses have been proposed. Extensive research has provided numerous answers regarding the pathogenesis, histopathologic evidence, and treatment of vitiligo. This discussion of vitiligo summarizes the varied clinical presentations of the disease, theories attempting to explain the mechanism of melanocyte destruction, histopathologic findings, and different treatment modalities currently available.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9591808     DOI: 10.1016/s0190-9622(98)70194-x

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  40 in total

1.  PIG3V, an immortalized human vitiligo melanocyte cell line, expresses dilated endoplasmic reticulum.

Authors:  I C Le Poole; R E Boissy; R Sarangarajan; J Chen; J J Forristal; P Sheth; W Westerhof; G Babcock; P K Das; C B Saelinger
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-05       Impact factor: 2.416

2.  Novel vitiligo susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis.

Authors:  Richard A Spritz; Katherine Gowan; Dorothy C Bennett; Pamela R Fain
Journal:  Am J Hum Genet       Date:  2004-01       Impact factor: 11.025

3.  Patients affected by vitiligo and autoimmune diseases do not show antibodies interfering with the activity of the melanocortin 1 receptor.

Authors:  P Agretti; G De Marco; D Sansone; C Betterle; G Coco; A Dimida; E Ferrarini; A Pinchera; P Vitti; M Tonacchera
Journal:  J Endocrinol Invest       Date:  2010-03-22       Impact factor: 4.256

4.  A novel linkage to generalized vitiligo on 4q13-q21 identified in a genomewide linkage analysis of Chinese families.

Authors:  Jian-Jun Chen; Wei Huang; Jin-Ping Gui; Sen Yang; Fu-Sheng Zhou; Quan-Geng Xiong; Hong-Bo Wu; Yong Cui; Min Gao; Wei Li; Jin-Xian Li; Kai-Lin Yan; Wen-Tao Yuan; Shi-Jie Xu; Jian-Jun Liu; Xue-Jun Zhang
Journal:  Am J Hum Genet       Date:  2005-04-04       Impact factor: 11.025

5.  Development of pemphigus vulgaris in a patient with vitiligo and Hashimoto's thyroiditis.

Authors:  B Yalçin; E Tamer; G G Toy; P Oztas; N Alli
Journal:  J Endocrinol Invest       Date:  2005-06       Impact factor: 4.256

6.  Disorders of pigmentation: global issues of major cosmetic concern.

Authors:  P E Grimes
Journal:  West J Med       Date:  1998-10

7.  Prevalence of choroidal nevus and retinal pigment epithelial alterations in vitiligo patients.

Authors:  Efrat Fleissig; Mor Pavlovksy; Anat Loewenstein; Dinah Zur; Hadas Newman; Shay Keren; Dafna Goldenberg; Efrat Bar-Ilan; Michaella Goldstein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-03-16       Impact factor: 3.117

8.  CTLA-4 A49G gene polymorphism is not associated with vitiligo in South Indian population.

Authors:  Farha Deeba; Rabbani Syed; Jariya Quareen; M A Waheed; Kaiser Jamil; Hanmanth Rao
Journal:  Indian J Dermatol       Date:  2010       Impact factor: 1.494

9.  Stability in vitiligo: why such a hullabaloo?

Authors:  Somesh Gupta
Journal:  J Cutan Aesthet Surg       Date:  2009-01

10.  Childhood vitiligo: response to methylprednisolone oral minipulse therapy and topical fluticasone combination.

Authors:  Imran Majid; Qazi Masood; Iffat Hassan; Dilshad Khan; Muzammil Chisti
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.